These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24265059)

  • 1. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
    Cabello-Vílchez AM; Martín-Navarro CM; López-Arencibia A; Reyes-Batlle M; Sifaoui I; Valladares B; Piñero JE; Lorenzo-Morales J
    Parasitol Res; 2014 Feb; 113(2):755-9. PubMed ID: 24265059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
    Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains.
    Rocha-Cabrera P; Reyes-Batlle M; Martín-Navarro CM; Dorta-Gorrín A; López-Arencibia A; Sifaoui I; Martínez-Carretero E; Piñero JE; Martín-Barrera F; Valladares B; Lorenzo-Morales J
    J Med Microbiol; 2015 Aug; 64(8):849-853. PubMed ID: 26293786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.
    Webster D; Umar I; Kolyvas G; Bilbao J; Guiot MC; Duplisea K; Qvarnstrom Y; Visvesvara GS
    Am J Trop Med Hyg; 2012 Oct; 87(4):715-8. PubMed ID: 22869634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping of potentially pathogenic Acanthamoeba strains isolated from nasal swabs of healthy individuals in Peru.
    Cabello-Vílchez AM; Martín-Navarro CM; López-Arencibia A; Reyes-Batlle M; González AC; Guerra H; Gotuzzo E; Valladares B; Piñero JE; Lorenzo-Morales J
    Acta Trop; 2014 Feb; 130():7-10. PubMed ID: 24140300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
    Sharma G; Kalra SK; Tejan N; Ghoshal U
    Exp Parasitol; 2020 Nov; 218():108008. PubMed ID: 32979343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
    Talbott M; Cevallos V; Chen MC; Chin SA; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
    Cornea; 2019 Oct; 38(10):1309-1313. PubMed ID: 31306283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysticidal activity of antifungals against different genotypes of Acanthamoeba.
    Iovieno A; Miller D; Ledee DR; Alfonso EC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5626-8. PubMed ID: 25001304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
    Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
    Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain.
    Martín-Navarro CM; Lorenzo-Morales J; Cabrera-Serra MG; Rancel F; Coronado-Álvarez NM; Piñero JE; Valladares B
    J Med Microbiol; 2008 Nov; 57(Pt 11):1399-1404. PubMed ID: 18927419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
    Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
    Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.
    Alizadeh H; Neelam S; Cavanagh HD
    Eye Contact Lens; 2009 Jan; 35(1):1-5. PubMed ID: 19125040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antifungal Drug Isavuconazole Is both Amebicidal and Cysticidal against Acanthamoeba castellanii.
    Shing B; Singh S; Podust LM; McKerrow JH; Debnath A
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amebicidal plants extracts].
    Derda M; Hadaś E; Thiem B; Sułek A
    Wiad Parazytol; 2004; 50(4):715-21. PubMed ID: 16862806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial effect of auranofin against Acanthamoeba spp.
    Loufouma Mbouaka A; Leitsch D; Koehsler M; Walochnik J
    Int J Antimicrob Agents; 2021 Nov; 58(5):106425. PubMed ID: 34419578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of voriconazole in combined acanthamoeba and fungal corneal ulcer.
    Gupta S; Shrivastava RM; Tandon R; Gogia V; Agarwal P; Satpathy G
    Cont Lens Anterior Eye; 2011 Dec; 34(6):287-9. PubMed ID: 21733740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.